GC-MS method development and validation for the determination of Short Chain Fatty Acids in human feces

), isobutyric acid and isovaleric acid) in human feces. Sample preparation was simplified while maintaining robustness, following systematic evaluation of homogenization, extraction solvents, and acidification conditions. The optimized method demonstrated high analytical performance, with limits of detection ranging from 0.01 to 0.52 μmol/g and good precision and accuracy in accordance with FDA and EMA bioanalytical guidelines Stability studies revealed that SCFAs remain stable in acidified fecal samples for up to 10 days without cold-chain requirements, while -80 °C storage was optimal for long-term preservation and 4 °C suitable for short-term handling. The applicability of the method was confirmed through analysis of samples collected from healthy volunteers. Overall, the developed approach provides a practical, high-throughput, and scalable tool for SCFA analysis, supporting applications in clinical research, metabolomics, and large-scale microbiome studies.

Authors

Institutions

Publication Details

Journal
Journal of Pharmaceutical and Biomedical Analysis
Published
2026-04-01
DOI
https://doi.org/10.1016/j.jpba.2026.117488
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GC-MS method development and validation for the determination of Short Chain Fatty Acids in human feces

Gika G Helen, Begou Olga, Theodoridis Georgios, Farantatou Konstantina et al.
Journal of Pharmaceutical and Biomedical Analysis
Gut microbiota and health
article

GC-MS method development and validation for the determination of Short Chain Fatty Acids in human feces

Gika G Helen, Begou Olga, Theodoridis Georgios, Farantatou Konstantina, Virgiliou Chistina, Gkanali Vasiliki
article en

Abstract

), isobutyric acid and isovaleric acid) in human feces. Sample preparation was simplified while maintaining robustness, following systematic evaluation of homogenization, extraction solvents, and acidification conditions. The optimized method demonstrated high analytical performance, with limits of detection ranging from 0.01 to 0.52 μmol/g and good precision and accuracy in accordance with FDA and EMA bioanalytical guidelines Stability studies revealed that SCFAs remain stable in acidified fecal samples for up to 10 days without cold-chain requirements, while -80 °C storage was optimal for long-term preservation and 4 °C suitable for short-term handling. The applicability of the method was confirmed through analysis of samples collected from healthy volunteers. Overall, the developed approach provides a practical, high-throughput, and scalable tool for SCFA analysis, supporting applications in clinical research, metabolomics, and large-scale microbiome studies.

Journal of Pharmaceutical and Biomedical AnalysisVol. 277
Aristotle University of Thessaloniki (GR), Hellenic Agency for Local Development and Local Government (GR), Centre for Research and Technology Hellas (GR)
HORIZON EUROPE European Innovation Council
Openalex Percentile: Top 29%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.